An Open Label, Safety Study to Assess the Potential for Adrenal Suppression.
Clinical trial NCT02932891 · COMPLETED
Trial details
- NCT number
- NCT02932891
- Sponsor
- Sun Pharmaceutical Industries, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-01
- Primary completion
- 2017-04-14
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.